Diagnosis and Treatment of Adenocarcinomas and Squamous Cell Carcinomas of the Lung. Journal of the advanced practitioner in oncology Das, M., Tisch, A. H. 2017; 8 (3): 267–72


Following years in which there were only modest gains in treatment options for non-small cell lung cancer, recognition of targetable mutations and immunogenicity of lung cancer now impact treatment decisions.

View details for PubMedID 29928550